The 2nd Brighton Tumour Microenvironment Conference will take place on 12–13 October 2026 at the Leonardo Royal Hotel Brighton Waterfront, Brighton, UK. The conference is organised and supported by the University of Brighton and the local cancer charity, the Sussex Cancer Fund. It will run in a hybrid format.

The aim of the Second Brighton Tumour Microenvironment Conference is to showcase cutting‑edge developments in tumour microenvironment (TME) research, with a focus on the mechanisms underpinning TME‑driven tumour progression and therapy resistance. The programme will explore extracellular matrix (ECM) dynamics, immune–TME interactions, the perivascular niche, tumour angiogenesis, and emerging therapeutic targets within the TME.

The Second Brighton Tumour Microenvironment Conference places strong emphasis on inclusivity and on supporting Early Career Researchers (ECRs) through dedicated opportunities to present their work at this meeting.

The Sussex Cancer Fund works to improve cancer care across Sussex by enhancing patient environments and supporting local, innovative research. Their support for this conference reflects their commitment to advancing novel therapies.

For more information, to submit and abstract, and register to attend, please visit the link below.